Exact Mass: 527.119216
Exact Mass Matches: 527.119216
Found 105 metabolites which its exact mass value is equals to given mass value 527.119216
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3-Carboxy-1-hydroxypropylthiamine diphosphate
3-Carboxy-1-hydroxypropyl-ThPP is an intermediate in Citrate cycle (TCA cycle). 3-Carboxy-1-hydroxypropyl-ThPP is the second to last step in the synthesis of Succinyl-CoA and is converted from 2-Oxoglutarate via the enzyme 2-oxoglutarate dehydrogenase E1 component (EC.1.2.4.2). It is then converted to S-Succinyldihydrolipoamide-E via the enzyme 2-oxoglutarate dehydrogenase E1 component (EC.1.2.4.2). [HMDB] 3-Carboxy-1-hydroxypropyl-ThPP is an intermediate in Citrate cycle (TCA cycle). 3-Carboxy-1-hydroxypropyl-ThPP is the second to last step in the synthesis of Succinyl-CoA and is converted from 2-Oxoglutarate via the enzyme 2-oxoglutarate dehydrogenase E1 component (EC.1.2.4.2). It is then converted to S-Succinyldihydrolipoamide-E via the enzyme 2-oxoglutarate dehydrogenase E1 component (EC.1.2.4.2).
Indoxacarb
CONFIDENCE standard compound; INTERNAL_ID 1226; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9824; ORIGINAL_PRECURSOR_SCAN_NO 9821 CONFIDENCE standard compound; INTERNAL_ID 1226; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9833; ORIGINAL_PRECURSOR_SCAN_NO 9832 CONFIDENCE standard compound; INTERNAL_ID 1226; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9846; ORIGINAL_PRECURSOR_SCAN_NO 9844 CONFIDENCE standard compound; INTERNAL_ID 1226; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9859; ORIGINAL_PRECURSOR_SCAN_NO 9856 CONFIDENCE standard compound; INTERNAL_ID 1226; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9868; ORIGINAL_PRECURSOR_SCAN_NO 9866 CONFIDENCE standard compound; INTERNAL_ID 1226; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9876; ORIGINAL_PRECURSOR_SCAN_NO 9875 CONFIDENCE standard compound; INTERNAL_ID 2598
Lumefantrine
C30H32Cl3NO (527.1549352000001)
Lumefantrine is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with artemether for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
2-(Dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
C30H32Cl3NO (527.1549352000001)
Indoxacarb
DPX-JW062
Cys Asp Gln Tyr
C21H29N5O9S (527.1685904000001)
Cys Asp Tyr Gln
C21H29N5O9S (527.1685904000001)
Cys Glu Asn Tyr
C21H29N5O9S (527.1685904000001)
Cys Glu Tyr Asn
C21H29N5O9S (527.1685904000001)
Cys Asn Glu Tyr
C21H29N5O9S (527.1685904000001)
Cys Asn Tyr Glu
C21H29N5O9S (527.1685904000001)
Cys Gln Asp Tyr
C21H29N5O9S (527.1685904000001)
Cys Gln Tyr Asp
C21H29N5O9S (527.1685904000001)
Cys Tyr Asp Gln
C21H29N5O9S (527.1685904000001)
Cys Tyr Glu Asn
C21H29N5O9S (527.1685904000001)
Cys Tyr Asn Glu
C21H29N5O9S (527.1685904000001)
Cys Tyr Gln Asp
C21H29N5O9S (527.1685904000001)
Asp Cys Gln Tyr
C21H29N5O9S (527.1685904000001)
Asp Cys Tyr Gln
C21H29N5O9S (527.1685904000001)
Asp Gln Cys Tyr
C21H29N5O9S (527.1685904000001)
Asp Gln Tyr Cys
C21H29N5O9S (527.1685904000001)
Asp Tyr Cys Gln
C21H29N5O9S (527.1685904000001)
Asp Tyr Gln Cys
C21H29N5O9S (527.1685904000001)
Glu Cys Asn Tyr
C21H29N5O9S (527.1685904000001)
Glu Cys Tyr Asn
C21H29N5O9S (527.1685904000001)
Glu Asn Cys Tyr
C21H29N5O9S (527.1685904000001)
Glu Asn Tyr Cys
C21H29N5O9S (527.1685904000001)
Glu Tyr Cys Asn
C21H29N5O9S (527.1685904000001)
Glu Tyr Asn Cys
C21H29N5O9S (527.1685904000001)
Asn Cys Glu Tyr
C21H29N5O9S (527.1685904000001)
Asn Cys Tyr Glu
C21H29N5O9S (527.1685904000001)
Asn Glu Cys Tyr
C21H29N5O9S (527.1685904000001)
Asn Glu Tyr Cys
C21H29N5O9S (527.1685904000001)
Asn Tyr Cys Glu
C21H29N5O9S (527.1685904000001)
Asn Tyr Glu Cys
C21H29N5O9S (527.1685904000001)
Gln Cys Asp Tyr
C21H29N5O9S (527.1685904000001)
Gln Cys Tyr Asp
C21H29N5O9S (527.1685904000001)
Gln Asp Cys Tyr
C21H29N5O9S (527.1685904000001)
Gln Asp Tyr Cys
C21H29N5O9S (527.1685904000001)
Gln Tyr Cys Asp
C21H29N5O9S (527.1685904000001)
Gln Tyr Asp Cys
C21H29N5O9S (527.1685904000001)
Tyr Cys Asp Gln
C21H29N5O9S (527.1685904000001)
Tyr Cys Glu Asn
C21H29N5O9S (527.1685904000001)
Tyr Cys Asn Glu
C21H29N5O9S (527.1685904000001)
Tyr Cys Gln Asp
C21H29N5O9S (527.1685904000001)
Tyr Asp Cys Gln
C21H29N5O9S (527.1685904000001)
Tyr Asp Gln Cys
C21H29N5O9S (527.1685904000001)
Tyr Glu Cys Asn
C21H29N5O9S (527.1685904000001)
Tyr Glu Asn Cys
C21H29N5O9S (527.1685904000001)
Tyr Asn Cys Glu
C21H29N5O9S (527.1685904000001)
Tyr Asn Glu Cys
C21H29N5O9S (527.1685904000001)
Tyr Gln Cys Asp
C21H29N5O9S (527.1685904000001)
Tyr Gln Asp Cys
C21H29N5O9S (527.1685904000001)
Benflumetol
C30H32Cl3NO (527.1549352000001)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
fluphenazine n-mustard dihydrochloride
C22H27Cl3F3N3S (527.0943268000001)
3,5-dichloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide
[3,4,5-triacetyloxy-6-[(2-nitrophenyl)carbamothioylamino]oxan-2-yl]methyl acetate
p-[4,5-dihydro-3-methyl-4-[[4-methyl-3-[(phenylamino)sulphonyl]phenyl]azo]-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid
C23H21N5O6S2 (527.0933206000001)
Benzenepropanoic acid, 4-[[4-(4-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-2-thiazolyl]methoxy]-2-methyl-
C28H24F3NO4S (527.1378060000001)
VT-1161
J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives C254 - Anti-Infective Agent > C514 - Antifungal Agent
Hydro-tris(3-phenylpyrazol-1-yl)borate potassium salt
(R)-2-(3-(3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl)phenoxy)butanoic acid
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide
Lumefantrine
C30H32Cl3NO (527.1549352000001)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
4-[[2-[3-[(4-Amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-4-hydroxybutanoic acid
2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol
C30H32Cl3NO (527.1549352000001)
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-6,8-dimethyl-2-(3-pyridinyl)-4-quinolinecarboxamide
[4-({3-[2-(1H-indol-3-yl)ethyl]-2-[(4-methoxyphenyl)imino]-4-oxo-1,3-thiazolidin-5-ylidene}methyl)phenoxy]acetic acid
[4-[2-(4-Bromophenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-(3-furanyl)methanone
C27H22BrN5O2 (527.0956772000001)
2-[[4-(4-chlorophenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]thio]-N-(3-methoxyphenyl)-2-phenylacetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
N3-[4-(difluoromethoxy)phenyl]-1-(3,4-dimethylphenyl)-N7-(2-hydroxyethyl)-2-mercaptoimidazo[1,2-a]pyridin-4-ium-3,7-dicarboxamide
C26H25F2N4O4S+ (527.1564493999999)
Beperidium iodide
Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
2-(3-carboxy-1-hydroxypropyl)-5-(2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-3-[(4-imino-2-methyl-3h-pyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium
[C16H25N4O10P2S]+ (527.076659)